ESC Professional Premium Access

Real-world data in ICD treatment

Event: ESC Congress 2022
Topic: Implantable Cardioverter-Defibrillator (ICD)
Session type: Moderated ePosters
Date: 29 August 2022
Time: 13:15 - 13:45

Congress Session

6 presentations in this session

Driving restrictions following defibrillator implantation significantly affect recipients' ability to maintain employment

Speaker: Doctor J. Bjerre (Copenhagen, DK)
Thumbnail

History of betablocker treatment breaks and risk of ventricular tachyarrhythmias among patients with heart failure and implantable cardioverter defibrillator: a nationwide cohort study

Speaker: Miss E. Mc Evoy Kjaer (Copenhagen, DK)
Thumbnail

Effect of defibrillator on long term all-cause mortality in patients with chronic kidney disease: an updated meta-analysis

Speaker: Doctor F. Aslam (Stony Brook, US)
Thumbnail

The role of trigger factors in the occurrence of appropriate ICD shocks and their prognostic implications

Speaker: Doctor T. Kleemann (Ludwigshafen, DE)
Thumbnail

Severity of chronic obstructive pulmonary disease and risk of one-year mortality after first-time implantation of implantable cardioverter defibrillator: a nationwide study

Speaker: Doctor A. Alhakak (Copenhagen, DK)
Thumbnail

The case against premature treatment of heart failure patients with implantable cardioverter-defibrillators: results from an institutional registry

Speaker: Doctor I. Prepolec (Zagreb, HR)
Thumbnail

6 speakers from this session

Doctor Jenny Bjerre

Gentofte University Hospital, Copenhagen (Denmark)
0 follower

Miss Emma Mc Evoy Kjaer

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)
0 follower

Doctor Faisal Aslam

Stony Brook University Hospital, Stony Brook (United States of America)
0 follower

Doctor Thomas Kleemann

Klinikum Ludwigshafen, Ludwigshafen (Germany)
1 follower

Doctor Amna Alhakak

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)
0 follower

Doctor Ivan Prepolec

University Hospital Centre Zagreb, Zagreb (Croatia)
0 follower

This platform is supported by

logo Novo Nordisk